# To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China

> **NCT06122012** · NA · UNKNOWN · sponsor: **Haisco Pharmaceutical Group Co., Ltd.** · enrollment: 136 (estimated)

## Conditions studied

- Diabetic Peripheral Neuropathic Pain

## Interventions

- **DRUG:** HSK16149 20mg BID

## Key facts

- **NCT ID:** NCT06122012
- **Lead sponsor:** Haisco Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-01
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-05
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2023-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06122012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06122012, "To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06122012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*